APA
Koutaïssoff S., Wellmann D., Coucke P., Ozsahin M., Pampallona S. & Mirimanoff R. O. (20000110). Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy. : International journal of radiation oncology, biology, physics.
Chicago
Koutaïssoff S, Wellmann D, Coucke P, Ozsahin M, Pampallona S and Mirimanoff R O. 20000110. Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy. : International journal of radiation oncology, biology, physics.
Harvard
Koutaïssoff S., Wellmann D., Coucke P., Ozsahin M., Pampallona S. and Mirimanoff R. O. (20000110). Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy. : International journal of radiation oncology, biology, physics.
MLA
Koutaïssoff S, Wellmann D, Coucke P, Ozsahin M, Pampallona S and Mirimanoff R O. Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy. : International journal of radiation oncology, biology, physics. 20000110.